Company Description
MEDIROM Healthcare Technologies Inc. provides holistic healthcare services in Japan.
It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The Relaxation Salon segment owns and franchises relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology.
This segment operates relaxation salons under the Re.Ra.Ku and Ruam Ruam brands. The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program, utilizing Lav, an on-demand health monitoring smartphone application and MOTHER Bracelet for fitness applications; and preventative healthcare services utilizing nutritionists and health nurses.
The Luxury Beauty segment manages and operates hair salons under the ZACC brand name. MEDIROM Healthcare Technologies Inc. also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques.
The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020.
MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
Country | Japan |
Founded | 2000 |
IPO Date | Dec 29, 2020 |
Industry | Personal Services |
Sector | Consumer Discretionary |
Employees | 434 |
CEO | Kouji Eguchi |
Contact Details
Address: 2-3-1 Daiba, Minato-ku Tokyo, M0 135-0091 Japan | |
Phone | 81-3-6721-7364 |
Website | medirom.co.jp |
Stock Details
Ticker Symbol | MRM |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $15.00 |
CIK Code | 0001819704 |
CUSIP Number | 58510H103 |
ISIN Number | US58510H1032 |
SIC Code | 7200 |
Key Executives
Name | Position |
---|---|
Kouji Eguchi | Chief Executive Officer and Representative Director |
Fumitoshi Fujiwara | Chief Financial Officer and Director |
Akira Aoki | Executive Officer and Chief Medical Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 24, 2024 | 6-K | Report of foreign issuer |
Apr 2, 2024 | 6-K | Report of foreign issuer |
Mar 29, 2024 | 6-K | Report of foreign issuer |
Mar 21, 2024 | 6-K | Report of foreign issuer |
Mar 15, 2024 | 6-K/A | Filing |
Mar 11, 2024 | 6-K | Report of foreign issuer |
Feb 22, 2024 | 6-K | Report of foreign issuer |
Jan 25, 2024 | 6-K | Report of foreign issuer |
Dec 29, 2023 | 6-K | Report of foreign issuer |
Dec 22, 2023 | 6-K | Report of foreign issuer |